EuroPharma Signs Exclusive Distirbution Agreement With New Chapter
Omega 3 oils containing DHA/EPA have become increasingly popular in response to the growing body of science that validates their numerous health benefits, yet few products have risen above the pack.
13/09/06 EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega for the health food/natural product retail channel. Vectomega is a natural marine complex made up of five different phospholipids, DHA, and EPA, along with proteins and amino acids as they occur in nature. Molecularly different from other omega-3’s on the market, Vectomega is 50 times more absorbable across cellular membranes than other DHA/EPA products.
Vectomega’s whole-food bioavailability was consistent with New Chapter’s guiding principles. “We have never made products with chemical isolates or harsh solvents, and we won’t,” states Paul Schulick, Co-CEO and founder of New Chapter. “Vectomega is the only omega 3 that delivers DHA and EPA in their natural phospholipid form without heat, solvents, and chemical modifications. The superior nature of this product inspired us to bring this to the natural products marketplace, and we are especially delighted that Terry Lemerond, one of the giants of our industry, brought this important innovation to New Chapter.
Terry Lemerond and the principal scientists will provide public support and their personal endorsement of the product, including public appearances at trade shows and industry events, and possible appearances on radio and television. Other agreement details are not disclosed.
“We are thrilled to be working with New Chapter to change the Omega 3 market,” stated Terry Lemerond, president of EuroPharma. “Vectomega surpasses other DHA/EPA products in terms of bioavailability, absorption and efficacy. New Chapter’s product launch with Vectomega will be the beginning of great changes in the Omega 3 category!”
Omega 3 oils containing DHA/EPA have become increasingly popular in response to the growing body of science that validates their numerous health benefits, yet few products have risen above the pack. Vectomega’s superior bioavailability, rapidly noticed results, and the novel dosage form are about to change that.
Research has confirmed that 50 times more Vectomega DHA and EPA crosses the cell membrane as compared to standard commercial fish oil products. This superior absorption is the result of a unique patented processing method that preserves the natural phospholipid composition of the omega-3 compounds in Vectomega.
